Abstract
Amniotic fluid (AF) contains a heterogeneous population of cells of fetal origin in which stem cells are present. These cells are characterized by the expression of mesenchymal (CD73, CD90, CD105) and neural (Nestin, β3-tubulin, NEFH) markers, and also some markers of pluripotency (Oct4, Nanog), and they are capable of differentiating into diverse derivatives in vitro. We have shown that epithelial markers (Keratin 19, Keratin 18, and p63) are expressed in AF stem cells simultaneously with mesenchymal ones. During cloning, colonies of cells with fibroblastoid and epithelioid cells are formed. The status and differentiation potential of stem cells from AF have been discussed.
Similar content being viewed by others
References
Anker in’ t, P.S., Scherjon, S.A., Kleijburg-van der Keur, C., et al. Amniotic Fluid As a Novel Source of Mesenchymal Stem Cells for Therapeutic Transplantation, Blood, 2003, vol. 102, no. 4, pp. 1548–1549.
Bertani, N., Matatesta, P., Volpi, G., et al., Neurogenic Potential of Human Mesenchymal Stem Cells Revisited: Analysis by Immunostaining, Timelapse Video and Microarray, J. Cell Sci., 2005, vol.118, pp. 3925–3936.
Campioni, D., Rizzo, R., Stignani, M., et al., A Decreased Positivity for CD90 on Human Mesenchymal Stromal Cells (MSCs) Is Associated with a Loss of Immunosuppressive Activity by MSCs, Cytometry Part B: Clin. Cytom., 2009, vol.76, no. 3, pp. 225–230.
Carraro, G., Perin, L., Sedrakyan, S., et al., Human Amniotic Fluid Stem Cells Can Integrate and Differentiate Into Epithelial Lung Lineages, Stem Cells, 2008, vol.26, no. 11, pp. 2902–2911.
Chang, F., Desmoplastic Small Round Cell Tumors: Cytologic, Histologic, and Immunohistochemical Features, Arch. Pathol. Lab. Med., 2006, vol.130, no. 5, pp. 728–732.
Chiavegato, A., Bollini, S., Pozzobon, M., et al., Human Amniotic Fluid-Derived Stem Cells Are Rejected after Transplantation in the Myocardium of Normal, Ischemic, Immuno-Suppressed or Immuno-Deficient Rat, J. Mol. Cell. Cardiol., 2007, vol.42, no. 4, pp. 746–759.
Coppi de, P., Bartsch, G., Jr., Siddiqui, M.M., et al., Isolation of Amniotic Stem Cells with Potential for Therapy, Nat. Biotechnol. 2007, vol.25, no. 1, pp. 100–106.
Dai, W. and Kloner, R.A., Myocardial Regeneration by Human Amniotic Fluid Stem Cells: Challenges to Be Overcome, J. Mol. Cell. Cardiol., 2007, vol.42, pp. 730–732.
Davydova, D.A., Vorotelyak, E.A., Smirnova, Yu.A., et al Cell Phenotypes in Human Amniotic Fluid, Acta Naturae, 2009, no. 2, pp. 98–103.
Delo, D.M., Coppi De P., Bartsch G.Jr., Atala A. Amniotic Fluid and Placental Stem Cells, in Methods in Enzymology, Burlington: Elsevier Acad. Press 2006, vol.419, pp. 426–438.
Ditadi, A., Coppi De P., Picone O. Et Al. Human and Murine Amniotic Fluid c-Kit+Lin-Cells Display Hematopoietic Activity, Blood, 2009, vol.113, no. 17, pp. 3953–3960.
Donaldson, A.E., Cai, J., Yang, M., and Iacovitti, L., Human Amniotic Fluid Stem Cells Do Not Differentiate into Dopamine Neurons in vitro or after Transplantation in vivo, Stem Cells Dev., 2009, vol.18, no. 7, pp. 1003–1012.
Ferdaos, N., Nathan, S., and Nordin, N., Prospective Full-Term-Derived Pluripotent Amniotic Fluid Stem (AFS) Cells, Med. J. Malaysia, 2008, vol.63, Suppl. A, pp. 75–76.
Fuchs, J.R., Kaviani, A., Oh, J.-T., et al., Diaphragmatic Reconstruction with Autologous Tendon Engineered from Mesenchymal Amniocytes, J. Pediatr. Surg., 2004, vol.39, no. 6, pp. 834–838.
Gemmis de, P., Lapucci, C., Bertelli, M., et al., A Real-Time PCR Approach to Evaluate Adipogenic Potential of Amniotic Fluid-Derived Human Mesenchymal Stem Cells, Stem Cells Dev., 2006, vol.15, pp. 719–728.
Hampton, T., Stem Cells Obtained from Amniotic Fluid, JAMA, 2007, vol.297, no. 8, p. 795.
Hoehn, H., Bryant, E.M., Karp, L.E., and Martin, G.M., Cultivated Cells from Diagnostic Amniocentesis in Second Trimester Pregnancies. I. Clonal Morphology and Growth Potential, Pediatr. Res., 1974, vol.8, pp. 746–754.
Kiseleva, E.V. and Vasil’ev, A.V., Multipotent Cells of Adipose Tissue Stroma, in Biologiya stvolovykh kletok i kletochnye tekhnologii (Stem Cell Biology and Cellular Technologies), Moscow: Meditsina, 2009, vol.2, pp. 124–162.
Kiseleva, E.V., Chermnykh, E.S., Vorotelyak, E.A., et al., Comparison of Fibroblasts-Like Cell Differentiation Capacities of Human Bone Marrow, Adipose Tissue, Hair Papilla and Dermal Fibroblasts, Tsitologiia, 2009, vol.51, no. 1, pp. 12–19.
Kolambkar, Y.M., Peister, A., Soker, S., et al., Chondrogenic Differentiation of Amniotic Fluid-Derived Stem Cells, J. Mol. Histol., 2007, vol.38, no. 5, pp. 405–413.
Kunisaki, S.M., Freedman, D.A., and Fauza, D.O., Fetal Tracheal Reconstruction with Cartilaginous Grafts Engineered from Mesenchymal Amniocytes, J. Pediatr. Surg., 2006, vol.41, pp. 675–682.
Kunisaki, S.M., Fuchs, J.R., Steigman, S.A., and Fauza, D.O., A Comparative Analysis of Cartilage Engineered from Different Perinatal Mesenchymal Progenitor Cells, Tissue Eng., 2007, vol.13, no. 11, pp. 2633–2644.
Lanfranchi, A., Porta, F., and Chirico, G., Stem Cells and the Frontiers of Neonatology, Early Hum. Dev., 2009, vol. 85,Suppl. 1, pp. 15–18.
Marcus, A.J. and Woodbury, D., Fetal Stem Cells from Extra-Embryonic Tissues: Do Not Discard, J. Cell. Mol. Med., 2008, vol.12, no. 3, pp. 730–742.
Mazzucchelli, I., Avanzini, M.A., Ciardelli, L., et al., Human Amniotic Fluid Cells Are Able to Produce IL-6 and IL-8, Am. J. Reprod. Immunol., 2004, vol.51, no. 3, pp. 198–203.
Nadri, S. and Soleimani, M., Comparative Analysis of Mesenchymal Stromal Cells from Murine Bone Marrow and Amniotic Fluid, Cytotherapy, 2007, vol.9, no. 8, pp. 729–737.
Niazi, M., Coleman, D.V., Mowbray, J.F., and Blunt, S., Tissue Typing Amniotic Fluid Cells: Potential Use for Detection of Contaminating Maternal Cells, J. Med. Genet., 1979, vol.16, pp. 21–23.
Pan, H.-C., Chen, C.-J., Cheng, F.-C., et al., Combination of G-CSF Administration and Human Amniotic Fluid Mesenchymal Stem Cell Transplantation Promotes Peripheral Nerve Regeneration, Neurochem. Res., 2009, vol.34, no. 3, pp. 518–527.
Payushina, O.V., Starostin, V.I., and Khrushchov, N.G., Multipotent Mesenchymal Stromal Cells: Characteristics, Potential for Differentiation, and Prospects of Use in Clinical Practice, in Biologiya stvolovykh kletok i kletochnye tekhnologii (Stem Cell Biology and Cellular Technologies), Moscow: Meditsina, 2009, vol.2, pp. 100–123.
Păunescu, V., Deak, E., Herman, D., et al., In vitro Differentiation of Human Mesenchymal Stem Cells to Epithelial Lineage, J. Cell. Mol. Med., 2007, vol.11, no. 3, p. 502508.
Peister, A., Deutsch, E.R., Kolambkar, Y., et al., Amniotic Fluid Stem Cells Produce Robust Mineral Deposits on Biodegradable Scaffolds, Tissue Eng., 2009, vol.15, no. 10, pp. 3129–3138.
Perin, L., Sedrakyan, S., Da, Sacco S., and De Filippo, R., Characterization of Human Amniotic Fluid Stem Cells and Their Pluripotential Capability, in Methods in Cell Biology, Burlington: Elsevier Acad. Press, 2008, vol.86, pp. 85–99.
Prusa, A.-R. and Hengstschläger, M., Amniotic Fluid Cells and Human Stem Cell Research—A New Connection, Med. Sci. Monit., 2002, vol.8, no. 11, pp. 253–257.
Romanov, Y.A., Svintsitskaya, V.A., and Smirnov, V.N., Searching for Alternative Sources of Postnatal Human Mesenchymal Stem Cells: Candidate MSC-Like Cells from Umbilical Cord, Stem Cells, 2003, vol.21, pp. 105–110.
Sartore, S., Lenzi, M., Angelini, A., et al., Amniotic Mesenchymal Cells Autotransplanted in a Porcine Model of Cardiac Ischemia Do Not Differentiate to Cardiogenic Phenotypes, Eur. J. Cardiothorac. Surg., 2005, vol.28, no. 5, pp. 677–684.
Saulnier, N., Lattanzi, W., Puglisi, M.A., et al., Mesenchymal Stromal Cells Multipotency and Plasticity: Induction toward the Hepatic Lineage, Eur. Rev. Med. Pharmacol. Sci., 2009, vol.13, no. Suppl. 1, pp. 71–78.
Schmidt, D., Achermann, J., Odermatt, B., et al., Prenatally Fabricated Autologous Human Living Heart Valves Based on Amniotic Fluid Derived Progenitor Cells As Single Cell Source, Circulation, 2007, vol.116, no. 11.
Sessarego, N., Parodi, A., Podest, M., et al., Multipotent Mesenchymal Stromal Cells from Amniotic Fluid: Solid Perspectives for Clinical Application, Haematologica, 2008, vol. 93, no. 3, pp. 339–346.
Shi, Y., Induced Pluripotent Stem Cells, New Tools for Drug Discovery and New Hope for Stem Cell Therapies, Curr. Mol. Pharmacol., 2009, vol.2, no. 1, pp. 15–18.
Siddiqui, M.M. and Atala, A., Amniotic Fluid-Derived Pluripotential Cells, in Handbook of Stem Cells, Burlington: Elsevier Acad. Press, 2004, vol.2, pp. 175–179.
Siegel, N., Valli, A., Fuchs, C., et al., Expression of MTOR Pathway Proteins in Human Amniotic Fluid Stem Cells, Int. J. Mol. Med., 2009, vol.23, pp. 779–784.
Steigman, S.A., Ahmed, A., Shanti, R.M., et al., Sternal Repair with Bone Grafts Engineered from Amniotic Mesenchymal Stem Cells, J. Pediatr. Surg., 2009, vol.44, pp. 1120–1126.
Takahashi, K. and Yamanaka, S., Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors, Cell, 2006, vol.126, no. 4, pp. 663–676.
Thomson, J.A., Itskovitz-Eldor, J., Shapiro, S.S., et al., Embryonic Stem Cell Lines Derived from Human Blastocysts, Science, 1998, vol.282, pp. 1145–1147.
Toda, A., Okabe, M., Yoshida, T., and Nikaido, T., The Potential of Amniotic Membrane/Amnion-Derived Cells for Regeneration of Various Tissues, J. Pharmacol. Sci., 2007, vol.105, pp. 215–228.
Torricelli, F., Brizzi, L., Bernabei, P.A., et al., Identification of Hematopoietic Progenitor Cells in Human Amniotic Fluid Before the 12th Week of Gestation, Ital. J. Anat. Embryol., 1993, vol.98, no. 2, pp. 119–126.
Tsai, M.-S., Hwang, S.-M., Tsai, Y.-L., et al., Clonal Amniotic Fluid-Derived Stem Cells Express Characteristics of Both Mesenchymal and Neural Stem Cells, Biol. Reprod., 2006, vol.74, pp. 545–551.
Tsai, M.-S., Lee, J.-L., Chang, Y.-J., and Hwang, S.-M., Isolation of Human Multipotent Mesenchymal Stem Cells from Second-Trimester Amniotic Fluid using a Novel Two-Stage Culture Protocol, Hum. Reprod., 2004, vol.19, no. 6, pp. 1450–1456.
Virtanen, I., Von Koskull, H., Lehto, V.-P et al., Cultured Human Amniotic Fluid Cells Characterized with Antibodies Against Intermediate Filaments in Indirect Immunofluorescence Microscopy, J. Clin. Invest., 1981, vol.68, pp. 1348–1355.
Walther, G., Gekas, J., and Bertrand, O.F., Amniotic Stem Cells for Cellular Cardiomyoplasty: Promises and Premises, Catheter. Cardiovasc. Interv., 2009, vol.73, pp. 917–924.
Wang, H., Chen, S., Cheng, X., et al., Differentiation of Human Amniotic Fluid Stem Cells into Cardiomyocytes through Embryonic Body Formation, Chin. J. Biotechn., 2008, vol.24, no. 9, pp. 1582–1587.
Yan, W.H., Lin, A., Chen, X.J., et al., Immunological Aspects of Human Amniotic Fluid Cells: Implication for Normal Pregnancy, Cell Biol. Int., 2008, vol.32, no. 1, pp. 93–99.
Yen, B.L., Huang, H.I., Chien, C.C., et al., Isolation of Multipotent Cells from Human Term Placenta, Stem Cells, 2005, vol.23, no. 1, pp. 3–9.
You, Q., Tong, X., Guan, Y., et al., The Biological Characteristics of Human Third Trimester Amniotic Fluid Stem Cells, J. Int. Med. Res., 2009, vol.37, pp. 105–112.
Zhang, P., Baxter, J., Vinod, K., et al., Endothelial Differentiation of Amniotic Fluid-Derived Stem Cells: Synergism of Biochemical and Shear Force Stimuli, Stem Cells Dev., 2009, vol.18, no. 9, pp. 1299–1308.
Zheng, Y.B., Gao, Z.L., Xie, C., et al., Characterization of Hepatogenic Differentiation of Mesenchymal Stem Cells from Human Amniotic Fluid and Human Bone Marrow: A Comparative Study, Cell Biol. Int., 2008, vol.32, no. 11, pp. 1439–1448.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © D.A. Davydova, 2010, published in Izvestiya Akademii Nauk, Seriya Biologicheskaya, 2010, No. 5, pp. 517–526.
Rights and permissions
About this article
Cite this article
Davydova, D.A. Stem cells in human amniotic fluid. Biol Bull Russ Acad Sci 37, 437–445 (2010). https://doi.org/10.1134/S1062359010050018
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1062359010050018